-transparent.png){kind=logo}
1,2-Epoxyhexahydrocannabinol is a metabolite of delta 1-tetrahydrocannabinol. Because many epoxides are mutagens, we investigated 1,2-epoxyhexahydrocannabinol as well as delta 1-tetrahydrocannabinol for mutagenicity with Salmonella typhimurium TA1535, TA1537, TA98 and TA100 in the presence and in the absence of S9 mix from liver homogenate of rats treated with Aroclor 1254. Additionally, an epoxide hydratase inhibitor was used in some experiments. Whereas several other epoxides and further positive controls, not requiring activation or activated under the same conditions, respectively, showed strong mutagenicity, no indications of a mutagenic hazard by 1,2-epoxyhexahydrocannabinol or by delta 1-tetrahydrocannabinol were found.
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
December 1982,
Biochemical and biophysical research communications,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
January 1979,
Acta pharmaceutica Suecica,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
January 1984,
Acta veterinaria Scandinavica,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
September 1982,
Xenobiotica; the fate of foreign compounds in biological systems,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
April 1985,
American journal of hospital pharmacy,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
May 2001,
Current protocols in toxicology,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
March 2018,
Bio-protocol,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
January 1984,
IARC scientific publications,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
January 1992,
Environmental and molecular mutagenesis,
H Glatt, and
A Ohlsson, and
S Agurell, and
F Oesch
June 1987,
Mutation research,
